Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-25-001080

Chief Development Officer acquired 23,306 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shankar Gopi · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-22 Grant or award : show line 1 in the form +23,306 50,806 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-22 Grant or award : show line 2 in the form Stock Option (Right to Buy) +139,838 139,838 D
Loading xslF345X05/form4.xml…